Skip to main content
Fig. 4 | Fluids and Barriers of the CNS

Fig. 4

From: Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model

Fig. 4

NCZ treatment has no effect on hAβ40 and hAβ42 plasma levels in hAPP mice. a hAβ40 levels (pg/ml) and b hAβ42 levels (pg/ml) in plasma samples from WT, hAPP, hAPP-NCZ and hAPP-NCZ/CSA mice. Data are given for each animal: WT (n = 10), hAPP (n = 15), hAPP-NCZ (n = 15), hAPP-NCZ/CSA (n = 15). Statistics: ANOVA; Data between groups are not significantly different

Back to article page

Fluids and Barriers of the CNS

ISSN: 2045-8118